MedTrace Logo

Virtual MOUD Treatment- Virtual POC Toxicology

NCT05448118 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-12-27

No results posted yet for this study

Summary

Care for Substance use disorders (SUD) such as Medication treatment of Opioid Use Disorder (MOUD) saves lives and is increasingly delivered virtually. Currently, 60% of VA outpatient addiction treatment occurs over video. However, toxicology testing, a major component of SUD care, currently requires in-person visits. A process for virtual point-of-care toxicology testing is needed. This research will develop a Virtual Point-of-Care Toxicology Testing Process for VA. This Pilot Trial will evaluate the feasibility, acceptability, and proximal effects of the process by evaluating provider and patient testing uptake, qualitative feedback, and health service use.

Conditions

  • Substance Use Disorder

Interventions

DIAGNOSTIC_TEST

Virtual POC Toxicology Test

Providers and patients will use Saliva Toxicology test at the point of care during virtual care visits.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Eric Hermes, MD · VA Connecticut Healthcare System West Haven Campus, West Haven, CT

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-09-01
Completion
2023-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05448118 on ClinicalTrials.gov